The National Pharmaceutical Pricing Authority (NPPA) on January 12, 2026, issued the Computation of Retail Price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg + Telmisartan IP 40 mg for M/s Exemed Pharmaceuticals. (Manufacturer) & M/s Eris Lifesciences Ltd. (Marketer).
The following has been stated namely: -
• The Retail Price has been computed for Each Film Coated Tablet Containing Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg + Telmisartan IP 40 mg for M/s Exemed Pharmaceuticals. (Manufacturer) & M/s Eris Lifesciences Ltd. (Marketer)
• The patent was expiring on October 2020
• The Proposed Price (Lower of Worked out and claimed price) per tablet is 18.56
[Notification No. 19(4969)/2025/DP/NPPA/Div.II]
